Fusion Antibodies has announced a £1.5m fundraising concurrently with a cost cutting exercise that should together provide it with an 18-month cash runway as it transitions towards a higher-value proposition. The fundraising is being conducted at 5p/share, a price that reflects the current adverse funding environment. A new strategy will see the focus shift towards commercialising the new integrated service offering and exploiting AI partnership opportunities, ahead of OptiMAL and OptiPhage. We ....
19 May 2023
Fusion Antibodies Update
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Fusion Antibodies Update
Fusion Antibodies Plc (FAB:LON) | 3.8 0 0.0% | Mkt Cap: 3.58m
- Published:
19 May 2023 -
Author:
Robin Davison | John Savin -
Pages:
7
Fusion Antibodies has announced a £1.5m fundraising concurrently with a cost cutting exercise that should together provide it with an 18-month cash runway as it transitions towards a higher-value proposition. The fundraising is being conducted at 5p/share, a price that reflects the current adverse funding environment. A new strategy will see the focus shift towards commercialising the new integrated service offering and exploiting AI partnership opportunities, ahead of OptiMAL and OptiPhage. We ....